When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Review Date: January 13, 2017
Expiration Date: January 12, 2020
Original Release Date: March 21, 2014
This basic-level course provides dental providers with an appreciation of the increasing scope of prescription drug abuse in the United States and a recognition that this problem, which crosses boundaries of gender, age, race, and socioeconomic status, is likely to exist within the patient populations they serve.
Dental providers frequently prescribe medications for their patients, especially for the control of pain. Although prescription drugs carry an aura of acceptability because they are legal and prescribed by professionals, the potential repercussions from using these drugs for reasons other than their intended purpose often go unrecognized by the user and unaddressed by the prescriber.
By becoming familiar with the basic pharmacology of the most commonly abused drugs, the risk factors for developing addictive behaviors and the manner in which these medications are commonly acquired, dental providers will be able to curb prescribing practices that contribute to this growing problem and better serve their patients and their communities as informed prevention advocates.
AGD Subject Code: 157
Western Schools designates this activity for 2 continuing education credits.
This course is an extract of, and should not be taken in conjunction with L0743 - Prescription Drug Abuse Among Dental Patients: Scope, Prevention, and Management Considerations, Updated 1st Edition (3 contact hours).
- Describe the history and scope of prescription drug abuse and the role of the dental professional.
- Define the terminology used in discussing prescription drug abuse.
- Identify the prescription drugs that are most commonly abused and the extent and impact of their non-medical use.
- Describe the populations most at risk for abusing prescription drugs and their access to these drugs.
- Discuss the tactics and resources available to manage and prevent prescription drug abuse in the dental practice.
Marnie Oakley, DMD, is the associate dean of clinical affairs at the University of Pittsburgh School of Dental Medicine, from which she received her DMD in 1992. Dr. Oakley served in both active duty and reserve roles as a dental officer in the United States Navy. As an experienced educator, she has taught numerous courses related to clinical dentistry, including Oral Diagnosis and Treatment Planning, Clinical Restorative Dentistry, and the Clinical Responsibility course series. In addition to being a published author and presenter on the subject of prescription drug abuse, Dr. Oakley was responsible for the development and implementation of the University of Pittsburgh School of Dental Medicine Comprehensive Care Program. Dr. Oakley also served as Chair of the American Dental Education Association (ADEA) Annual Session Planning Committee for two consecutive years, for which she received a Presidential Citation. She served in officer positions in several ADEA committees and groups. Dr. Oakley maintains membership in numerous professional organizations, including the American Dental Association (ADA), Pennsylvania Dental Association (PDA), Western Pennsylvania Dental Association (WPDA), Omicron Kappa Upsilon, and the Academy of General Dentistry.
Jean O’Donnell, DMD, MSN, is the associate dean for for academic affairs at the University of Pittsburgh School of Dental Medicine, from which she received her DMD in 1990. Within the same institution, she is an associate professor in the department of Restorative Dentistry and Comprehensive Care. Dr. O’Donnell holds a bachelor’s degree in nursing from Pennsylvania State University and a master’s degree in nursing from the University of Pittsburgh. She is a graduate of the American Dental Education Association (ADEA) Leadership Institute and currently serves as one of the university’s liaisons to the ADEA Commission on Change and Innovation in Dental Education. She is a member of Omicron Kappa Upsilon. Prescription drug abuse and tobacco cessation are among Dr. O’Donnell’s special interests.
Michael A. Zemaitis, PhD, holds a bachelor’s degree in pharmacy and a PhD in pharmacology. He is a professor in the Department of Pharmaceutical Sciences in the University of Pittsburgh School of Pharmacy, and he teaches in the professional and graduate programs in the School of Pharmacy and the School of Dental Medicine. Dr. Zemaitis’s current area of research interest is biochemical pharmacology, with a special interest in drug and metabolite analysis in biological fluids. He actively supports several pharmacy-related policy issues, including “Project Life Line,” a program to have community pharmacies provide the narcotic antidote naloxone to high-risk opiate users to prevent overdose deaths.
- Contact hours will be awarded for up to one (1) year from the date of purchase or through the expiration date indicated above, whichever date comes first.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that the course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
- There are no prerequisites for this course.